<DOCTYPE html>

<html>
<head>
<title>OtoProtein: Site Testing</title>
<link href="site.css" rel="stylesheet">
</head>
<body>

<nav id="nav01"></nav>

<div id="main">
  <h1>OtoProtein: Site Testing</h1> 
  <p>The OtoProtein project combines the expertise of researchers from the <a href="http://www.medicine.uiowa.edu/morl/">Molecular Otolaryngology and Renal Research Laboratories (MORL)</a> and the <a href="http://www.medicine.uiowa.edu/biochem/labs/schnieders/">Michael Schnieders Laboratory</a> at the University of Iowa to analyze proteins and molecules implicated in hearing loss. A list of the proteins and molecules currently being studied along with their structures can be found online at <a href="https://github.com/wtollefson/dvd-structures/tree/nshl_protein_study">https://github.com/wtollefson/dvd-structures/tree/nshl_protein_study.</a> All structures in the OtoProtein project were chosen from a comprehensive list of deafness associated genetic variants identified in the Deafness Variation Database (DVD) and molecular biophysics software algorithms available through <a href="http://ffx.biochem.uiowa.edu">Force Field X (FFX)</a> were applied to the proteins. Shown below are examples of the OtoProteins that have been researched and refined using FFX algorithms.</p>

  <h2>DVD Proteins</h2>
  <table>
  <tr>
  <td width="50%" align="center">
  <img src="./images/GJB2Hexamer_Large.png" alt="GJB2 Hexamer" style="width:600px;height:400px;">
  <p>GJB2 Hexamer: A cell membrane protein. </p>
  </td>
  <td width="50%" align="center">
  <img src="./images/MYO7A_K268R.png" alt="MYO7A" style="width:600px;height:400px;">
  <p>MYO7A: Solvent exposed K268R variant.</p>
  </td>
  </tr>
  </table>
  <table>
  <tr>
  <td width="50%" align="center">
  <img src="./images/DFNB31.png" alt="DFNB31" style="width:600px;height:485px;">
  <p>DFNB31: The DFNB31 structure pictured in purple was obtained from SwissProt. After rotamer optimization, the optimized structure pictured in blue shows an increase in beta sheet.</p>
  </td>
  <td width="50%" align="center">
  <img src="./images/USH2A_R1777W_final.png" alt="USH2A R1777W" style="width:600px;height:485px;">
  <p>USH2A R1777W: The arginine to tryptophan variant shown in green resulted in a free energy change of -1.42 kcal/mol. The variant showed increase hydrogen bonding.</p>
  </td>
  </tr>
  </table>
  <table>
  <tr>
  <td width="50%" align="center">
  <img src="./images/USH2A_R666G.png" alt="USH2A R666G" style="width:600px;height:485px;">
  <p>USH2A R666G: Proteins with missense mutations are solvated in a water box before simulation. This variant resulted in a pathogenic free energy change of 2.51 kcal/mol.</p>
  </td>
  <td width="50%" align="center">
  <img src="./images/USH2A_C934W_fit.png" alt="USH2A C934W" style="width:600px;height:485px;">
  <p>USH2A C934W: The C934W variant is displayed in green. This solvent exposed variant resulted in a likely benign free energy change of 1.21 kcal/mol.</p>
  </td>
  </tr>
  </table>
  <table>
  <tr>
  <td width="50%" align="center">
  <img src="./images/USH2A_T3976M.png" alt="USH2A T3976M" style="width:600px;height:400px;">
  <p>USH2A T3976M: The wildtype and variant are displayed in red and blue respectively. A free energy change of 0.49 kcal/mol and the DVD classification both imply that the variant is benign.</p>
  </td>
  <td width="50%" align="center">
  <img src="./images/GIPC3.png" alt="GIPC3" style="width:600px;height:400px;">
  <p>GIPC3: The GIPC3 protein is commonly implicated in hearing loss.</p>
  </td>
  </tr>
  </table>

  <p> Contact us at <a class="externalLink" href="mailto:mallory-tollefson@gmail.com">mallory-tollefson@gmail.com.</a></p>

  <footer id="foot01"></footer>
</div>

<script src="script.js"></script>

</body>
</html>
